Pharma Journalist - Page 62 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Approves Updated Label for Lilly’s Amyvid to Aid Alzheimer’s Diagnosis

Vor Bio, RemeGen Sign Exclusive Global License Deal for Late-Stage Autoimmune Therapy

Medera’s Novoheart Teams Up to Develop Mini-Heart Models for Hypoplastic Left Heart Syndrome Treatment

Novo Nordisk’s Ozempic Recommended by EU for Peripheral Arterial Disease in Type 2 Diabetes

Datroway Approved in U.S. for Advanced EGFR-Mutated Lung Cancer

argenx Wins EU Approval for VYVGART SC to Treat CIDP

Harbour BioMed and Otsuka Partner Globally to Develop BCMAxCD3 Bispecific T-Cell Engagers

Archeus Technologies Gets FDA Clearance for ART-101 Prostate Cancer Trial

Health Canada Approves Novartis’ KISQALI for High-Risk Early Breast Cancer

Advarra Launches AI Council to Boost Innovation in Clinical Trials